# Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
Canonical URL: https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-second-quarter-financial-results
Ticker: TWST
Company: Twist Bioscience Corporation
Source: Twist Bioscience Corporation
Published: 2026-05-04 11:15 EST
Original Source URL: https://investors.twistbioscience.com
## Summary

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 4, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026.

## Article Body
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 4, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026.
## Recent Company News
- 2026-05-27 12:00 EST — [Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference) — Source: Twist Bioscience Corporation
- 2026-05-05 12:00 EST — [Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/TWST/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Twist Bioscience Corporation
- 2026-05-04 11:20 EST — [Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences](https://biopharmsignal.com/news/TWST/twist-bioscience-expands-clonal-genes-offering-to-include-long-and-complex-sequences) — Source: Twist Bioscience Corporation
- 2026-05-04 11:15 EST — [Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-second-quarter-financial-results) — Source: Twist Bioscience Corporation
- 2026-04-21 12:00 EST — [Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026](https://biopharmsignal.com/news/TWST/twist-bioscience-to-report-fiscal-2026-second-quarter-financial-results-on-monday-may-4-2026) — Source: Twist Bioscience Corporation
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)